ERBB2 c.739_740delinsAT ;(p.P247I)

Variant ID: 17-37866434-CC-AT

NM_004448.2(ERBB2):c.739_740delinsAT;(p.P247I)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names.

Mabs
Wilkinson, Ian I; Hale, Geoff G
Publication Date: 2022

Variant appearance in text: HER2: P247I
PubMed Link: 36109838
Variant Present in the following documents:
  • KMAB_14_2123299.pdf
View BVdb publication page



Fc-Engineering for Modulated Effector Functions-Improving Antibodies for Cancer Treatment.

Antibodies (Basel, Switzerland)
Liu, Rena R; Oldham, Robert J RJ; Teal, Emma E; Beers, Stephen A SA; Cragg, Mark S MS
Publication Date: 2020-11-17

Variant appearance in text: HER2: P247I
PubMed Link: 33212886
Variant Present in the following documents:
  • Main text
  • antibodies-09-00064.pdf
View BVdb publication page



Harnessing the immune system via FcγR function in immune therapy: a pathway to next-gen mAbs.

Immunology And Cell Biology
Chenoweth, Alicia M AM; Wines, Bruce D BD; Anania, Jessica C JC; Mark Hogarth, P P
Publication Date: 2020-04

Variant appearance in text: HER2: P247I
PubMed Link: 32157732
Variant Present in the following documents:
  • IMCB-9999-na.pdf
View BVdb publication page